RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK: LLBT) announced today that patient data is being provided to Nanyang Technical University, which the engineers will utilize for further development and improvement the Company’s First Warning System, a system designed to assist in the early detection of breast cancer.
